http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 09 Mar 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html <p>ROCKAWAY, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2025, after the close of the market on Thursday, March 19, 2026.</p> <p>Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:</p> <p><strong><em>Thursday, March 19, 4:30 PM EDT</em></strong><br/><strong>Dial-In:</strong> (646) 931-3860<br/><strong>Webinar ID:</strong> 886 9421 4883<br/><strong>Passcode: </strong>014212<br/><strong>Registration Link:</strong> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=KIF4Yn-JJOAitVnTb69e3cQLF22PBkb6WdbT5-PAUPC-gx1DgMziuIkrYsmxrr1v-pEyhth2dknst-rC8ON1pCzPa-evZIrpLSRb98DOlOjKDD07geaudMbc6mTMfNsm6Z3jyj4AhyRzX1uUtkridw==" rel="nofollow" target="_blank">Click here </a>to participate and ask questions on http://www.streetinsider.com/Press+Releases/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html Mon, 09 Mar 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html <p>ROCKAWAY, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2025, after the close of the market on Thursday, March 19, 2026.</p> <p>Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:</p> <p><strong><em>Thursday, March 19, 4:30 PM EDT</em></strong><br/><strong>Dial-In:</strong> (646) 931-3860<br/><strong>Webinar ID:</strong> 886 9421 4883<br/><strong>Passcode: </strong>014212<br/><strong>Registration Link:</strong> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=KIF4Yn-JJOAitVnTb69e3cQLF22PBkb6WdbT5-PAUPC-gx1DgMziuIkrYsmxrr1v-pEyhth2dknst-rC8ON1pCzPa-evZIrpLSRb98DOlOjKDD07geaudMbc6mTMfNsm6Z3jyj4AhyRzX1uUtkridw==" rel="nofollow" target="_blank">Click here </a>to participate and ask questions on http://www.streetinsider.com/Press+Releases/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html Mon, 09 Mar 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html <p>ROCKAWAY, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2025, after the close of the market on Thursday, March 19, 2026.</p> <p>Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:</p> <p><strong><em>Thursday, March 19, 4:30 PM EDT</em></strong><br/><strong>Dial-In:</strong> (646) 931-3860<br/><strong>Webinar ID:</strong> 886 9421 4883<br/><strong>Passcode: </strong>014212<br/><strong>Registration Link:</strong> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=KIF4Yn-JJOAitVnTb69e3cQLF22PBkb6WdbT5-PAUPC-gx1DgMziuIkrYsmxrr1v-pEyhth2dknst-rC8ON1pCzPa-evZIrpLSRb98DOlOjKDD07geaudMbc6mTMfNsm6Z3jyj4AhyRzX1uUtkridw==" rel="nofollow" target="_blank">Click here </a>to participate and ask questions on http://www.streetinsider.com/Press+Releases/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html Mon, 09 Mar 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html <p>ROCKAWAY, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2025, after the close of the market on Thursday, March 19, 2026.</p> <p>Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:</p> <p><strong><em>Thursday, March 19, 4:30 PM EDT</em></strong><br/><strong>Dial-In:</strong> (646) 931-3860<br/><strong>Webinar ID:</strong> 886 9421 4883<br/><strong>Passcode: </strong>014212<br/><strong>Registration Link:</strong> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=KIF4Yn-JJOAitVnTb69e3cQLF22PBkb6WdbT5-PAUPC-gx1DgMziuIkrYsmxrr1v-pEyhth2dknst-rC8ON1pCzPa-evZIrpLSRb98DOlOjKDD07geaudMbc6mTMfNsm6Z3jyj4AhyRzX1uUtkridw==" rel="nofollow" target="_blank">Click here </a>to participate and ask questions on http://www.streetinsider.com/Globe+Newswire/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html Mon, 09 Mar 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html <p>ROCKAWAY, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2025, after the close of the market on Thursday, March 19, 2026.</p> <p>Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:</p> <p><strong><em>Thursday, March 19, 4:30 PM EDT</em></strong><br/><strong>Dial-In:</strong> (646) 931-3860<br/><strong>Webinar ID:</strong> 886 9421 4883<br/><strong>Passcode: </strong>014212<br/><strong>Registration Link:</strong> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=KIF4Yn-JJOAitVnTb69e3cQLF22PBkb6WdbT5-PAUPC-gx1DgMziuIkrYsmxrr1v-pEyhth2dknst-rC8ON1pCzPa-evZIrpLSRb98DOlOjKDD07geaudMbc6mTMfNsm6Z3jyj4AhyRzX1uUtkridw==" rel="nofollow" target="_blank">Click here </a>to participate and ask questions on http://www.streetinsider.com/Globe+Newswire/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html Mon, 09 Mar 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html <p>ROCKAWAY, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2025, after the close of the market on Thursday, March 19, 2026.</p> <p>Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:</p> <p><strong><em>Thursday, March 19, 4:30 PM EDT</em></strong><br/><strong>Dial-In:</strong> (646) 931-3860<br/><strong>Webinar ID:</strong> 886 9421 4883<br/><strong>Passcode: </strong>014212<br/><strong>Registration Link:</strong> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=KIF4Yn-JJOAitVnTb69e3cQLF22PBkb6WdbT5-PAUPC-gx1DgMziuIkrYsmxrr1v-pEyhth2dknst-rC8ON1pCzPa-evZIrpLSRb98DOlOjKDD07geaudMbc6mTMfNsm6Z3jyj4AhyRzX1uUtkridw==" rel="nofollow" target="_blank">Click here </a>to participate and ask questions on http://www.streetinsider.com/Globe+Newswire/electroCore+to+Announce+Fourth+Quarter+and+Full+Year+Ended+December+31%2C+2025%2C+Financial+Results+on+Thursday%2C+March+19%2C+2026/26129182.html Mon, 09 Mar 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+26++Filed+by%3A+Goldberger+Daniel+S/25909174.html si-local-file:///var/storage/secattach/20260128/25909174.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+26++Filed+by%3A+Goldberger+Daniel+S/25909174.html Wed, 28 Jan 2026 16:30:00 -0400 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+26++Filed+by%3A+Goldberger+Daniel+S/25909174.html si-local-file:///var/storage/secattach/20260128/25909174.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+26++Filed+by%3A+Goldberger+Daniel+S/25909174.html Wed, 28 Jan 2026 16:30:00 -0400 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+26++Filed+by%3A+Lev+Joshua+S./25909185.html si-local-file:///var/storage/secattach/20260128/25909185.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+26++Filed+by%3A+Lev+Joshua+S./25909185.html Wed, 28 Jan 2026 16:30:00 -0400 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+26++Filed+by%3A+Lev+Joshua+S./25909185.html si-local-file:///var/storage/secattach/20260128/25909185.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+26++Filed+by%3A+Lev+Joshua+S./25909185.html Wed, 28 Jan 2026 16:30:00 -0400 ECOR O.07507914 http://www.streetinsider.com/Analyst+PT+Change/electroCore+Inc.+%28ECOR%29+PT+Lowered+to+%2418+at+H.C.+Wainwright/25890047.html (Updated - January 26, 2026 6:48 AM EST) <p>H.C. Wainwright analyst Swayampakula Ramakanth lowered the price target on electroCore Inc. (NASDAQ: ECOR) to $18.00 (from $25.00) while maintaining a Buy rating.</p><p>The analyst commented: "On January 20, 2026, electroCore announced preliminary FY2025 revenues of $31.8M - $32.0M (+26% YoY), in line with the guidance midpoint (range: $31.5M - $32.5M). Regarding 4Q25, management reported preliminary revenue range of $9.0M - $9.2M (+30% YoY). The company exited 2025 with a cash balance of $11.6M compared to $13.2M at the end of 3Q25 , implying a net quarterly cash burn of approximately $1.6M). Management plans http://www.streetinsider.com/Analyst+PT+Change/electroCore+Inc.+%28ECOR%29+PT+Lowered+to+%2418+at+H.C.+Wainwright/25890047.html Mon, 26 Jan 2026 06:48:32 -0400 ECOR http://www.streetinsider.com/Analyst+Comments/electroCore+Inc.+%28ECOR%29+PT+Lowered+to+%2418+at+H.C.+Wainwright/25890047.html (Updated - January 26, 2026 6:48 AM EST) <p>H.C. Wainwright analyst Swayampakula Ramakanth lowered the price target on electroCore Inc. (NASDAQ: ECOR) to $18.00 (from $25.00) while maintaining a Buy rating.</p><p>The analyst commented: "On January 20, 2026, electroCore announced preliminary FY2025 revenues of $31.8M - $32.0M (+26% YoY), in line with the guidance midpoint (range: $31.5M - $32.5M). Regarding 4Q25, management reported preliminary revenue range of $9.0M - $9.2M (+30% YoY). The company exited 2025 with a cash balance of $11.6M compared to $13.2M at the end of 3Q25 , implying a net quarterly cash burn of approximately $1.6M). Management plans http://www.streetinsider.com/Analyst+Comments/electroCore+Inc.+%28ECOR%29+PT+Lowered+to+%2418+at+H.C.+Wainwright/25890047.html Mon, 26 Jan 2026 06:48:32 -0400 ECOR http://www.streetinsider.com/Corporate+News/electroCore+begins+study+of+nerve+stimulator+for+PTSD+treatment/25871574.html <p>electroCore Inc. (NASDAQ: ECOR) announced that Acacia Clinics and the Vagus Nerve Society have launched a study to examine the company's gammaCore Sapphire device as an adjunctive treatment for post-traumatic stress disorder symptoms.</p><p>The study, led by Danielle DeSouza at Acacia Clinics, will evaluate the safety and effectiveness of the non-invasive vagus nerve stimulator in treating PTSD symptoms. The research will measure adverse events related to the treatment and assess changes in PTSD severity using the Clinician-Administered PTSD Scale over a 12-week treatment period.</p><p>The trial will enroll up to 40 participants aged 18 to 70 who have been diagnosed with PTSD. http://www.streetinsider.com/Corporate+News/electroCore+begins+study+of+nerve+stimulator+for+PTSD+treatment/25871574.html Wed, 21 Jan 2026 08:02:03 -0400 ECOR http://www.streetinsider.com/Press+Releases/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html <p>ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and the Vagus Nerve Society have launched a new research initiative to explore the extent to which gammaCore™ Sapphire, electroCore’s non-invasive vagus nerve stimulator (nVNS), can be used as an adjunctive treatment of symptoms associated with PTSD.</p> <p>The study entitled “<em>Non-Invasive Vagus Nerve Stimulation (nVNS) for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder,</em>” will be led by Danielle DeSouza MSc, PhD, VP of Research at Acacia Clinics (“the Investigator”). The http://www.streetinsider.com/Press+Releases/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html Wed, 21 Jan 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html <p>ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and the Vagus Nerve Society have launched a new research initiative to explore the extent to which gammaCore™ Sapphire, electroCore’s non-invasive vagus nerve stimulator (nVNS), can be used as an adjunctive treatment of symptoms associated with PTSD.</p> <p>The study entitled “<em>Non-Invasive Vagus Nerve Stimulation (nVNS) for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder,</em>” will be led by Danielle DeSouza MSc, PhD, VP of Research at Acacia Clinics (“the Investigator”). The http://www.streetinsider.com/Press+Releases/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html Wed, 21 Jan 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html <p>ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and the Vagus Nerve Society have launched a new research initiative to explore the extent to which gammaCore™ Sapphire, electroCore’s non-invasive vagus nerve stimulator (nVNS), can be used as an adjunctive treatment of symptoms associated with PTSD.</p> <p>The study entitled “<em>Non-Invasive Vagus Nerve Stimulation (nVNS) for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder,</em>” will be led by Danielle DeSouza MSc, PhD, VP of Research at Acacia Clinics (“the Investigator”). The http://www.streetinsider.com/Press+Releases/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html Wed, 21 Jan 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html <p>ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and the Vagus Nerve Society have launched a new research initiative to explore the extent to which gammaCore™ Sapphire, electroCore’s non-invasive vagus nerve stimulator (nVNS), can be used as an adjunctive treatment of symptoms associated with PTSD.</p> <p>The study entitled “<em>Non-Invasive Vagus Nerve Stimulation (nVNS) for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder,</em>” will be led by Danielle DeSouza MSc, PhD, VP of Research at Acacia Clinics (“the Investigator”). The http://www.streetinsider.com/Globe+Newswire/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html Wed, 21 Jan 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html <p>ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and the Vagus Nerve Society have launched a new research initiative to explore the extent to which gammaCore™ Sapphire, electroCore’s non-invasive vagus nerve stimulator (nVNS), can be used as an adjunctive treatment of symptoms associated with PTSD.</p> <p>The study entitled “<em>Non-Invasive Vagus Nerve Stimulation (nVNS) for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder,</em>” will be led by Danielle DeSouza MSc, PhD, VP of Research at Acacia Clinics (“the Investigator”). The http://www.streetinsider.com/Globe+Newswire/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html Wed, 21 Jan 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Globe+Newswire/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html <p>ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and the Vagus Nerve Society have launched a new research initiative to explore the extent to which gammaCore™ Sapphire, electroCore’s non-invasive vagus nerve stimulator (nVNS), can be used as an adjunctive treatment of symptoms associated with PTSD.</p> <p>The study entitled “<em>Non-Invasive Vagus Nerve Stimulation (nVNS) for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder,</em>” will be led by Danielle DeSouza MSc, PhD, VP of Research at Acacia Clinics (“the Investigator”). The http://www.streetinsider.com/Globe+Newswire/Acacia+Clinics+and+Vagus+Nerve+Society+Conduct+Study+Using+electroCore%E2%80%99s+gammaCore+Sapphire+for+Adjunctive+Treatment+of+Symptoms+Associated+with+Post-Traumatic+Stress+Disorder+%28%E2%80%9CPTSD%E2%80%9D%29/25871531.html Wed, 21 Jan 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+20/25868180.html si-local-file:///var/storage/secattach/20260120/25868180.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+20/25868180.html Tue, 20 Jan 2026 16:06:00 -0400 ECOR O.07507914 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+20/25868180.html si-local-file:///var/storage/secattach/20260120/25868180.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++electroCore%2C+Inc.+++++++++For%3A+Jan+20/25868180.html Tue, 20 Jan 2026 16:06:00 -0400 ECOR O.07507914 http://www.streetinsider.com/Corporate+News/electroCore+expects+26%25+revenue+growth+to+%2432+million+in+2025/25864936.html <p>electroCore Inc. (NASDAQ: ECOR) provided preliminary financial guidance indicating record revenue of approximately $31.8 million to $32.0 million for full-year 2025, representing 26% growth over 2024 revenue of $25.2 million.</p><p>The bioelectronic technology company expects fourth quarter 2025 revenue of approximately $9.0 million to $9.2 million, which would represent 30% growth compared to the fourth quarter of 2024.</p><p>The company reported a cash, cash equivalents, and marketable securities balance of approximately $11.6 million as of December 31, 2025, down from approximately $13.2 million as of September 30, 2025.</p><p>electroCore plans to provide detailed operational and financial updates during its fourth quarter and full-year http://www.streetinsider.com/Corporate+News/electroCore+expects+26%25+revenue+growth+to+%2432+million+in+2025/25864936.html Tue, 20 Jan 2026 08:02:11 -0400 ECOR http://www.streetinsider.com/Press+Releases/electroCore+Provides+Preliminary+Full-Year+2025+Business+Update%3B+Expects+%7E26%25+Revenue+Growth+to+%7E%2431.8%E2%80%93%2432.0+Million/25864890.html <ul><li style="text-align:left;"><em>Record revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0 - $9.2 million for the three months ended December 31, 2025 </em></li><li style="text-align:left;"><em>Revenue growth of approximately 26% over full-year 2024</em></li><li style="text-align:left;"><em>Cash, cash equivalents, and marketable securities (“Total Cash”) balance of approximately $11.6 million as of December 31, 2025 </em><br/><br/></li></ul> <p align="left">ROCKAWAY, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today provided select unaudited preliminary financial guidance for the full year and fourth quarter of 2025.</p> <p align="left"><strong>Financial Guidance</strong><br/>Preliminary unaudited financial guidance http://www.streetinsider.com/Press+Releases/electroCore+Provides+Preliminary+Full-Year+2025+Business+Update%3B+Expects+%7E26%25+Revenue+Growth+to+%7E%2431.8%E2%80%93%2432.0+Million/25864890.html Tue, 20 Jan 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/electroCore+Provides+Preliminary+Full-Year+2025+Business+Update%3B+Expects+%7E26%25+Revenue+Growth+to+%7E%2431.8%E2%80%93%2432.0+Million/25864890.html <ul><li style="text-align:left;"><em>Record revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0 - $9.2 million for the three months ended December 31, 2025 </em></li><li style="text-align:left;"><em>Revenue growth of approximately 26% over full-year 2024</em></li><li style="text-align:left;"><em>Cash, cash equivalents, and marketable securities (“Total Cash”) balance of approximately $11.6 million as of December 31, 2025 </em><br/><br/></li></ul> <p align="left">ROCKAWAY, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today provided select unaudited preliminary financial guidance for the full year and fourth quarter of 2025.</p> <p align="left"><strong>Financial Guidance</strong><br/>Preliminary unaudited financial guidance http://www.streetinsider.com/Press+Releases/electroCore+Provides+Preliminary+Full-Year+2025+Business+Update%3B+Expects+%7E26%25+Revenue+Growth+to+%7E%2431.8%E2%80%93%2432.0+Million/25864890.html Tue, 20 Jan 2026 08:00:00 -0400 A.15536158 ECOR O.07507914 http://www.streetinsider.com/Press+Releases/electroCore+Provides+Preliminary+Full-Year+2025+Business+Update%3B+Expects+%7E26%25+Revenue+Growth+to+%7E%2431.8%E2%80%93%2432.0+Million/25864890.html <ul><li style="text-align:left;"><em>Record revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0 - $9.2 million for the three months ended December 31, 2025 </em></li><li style="text-align:left;"><em>Revenue growth of approximately 26% over full-year 2024</em></li><li style="text-align:left;"><em>Cash, cash equivalents, and marketable securities (“Total Cash”) balance of approximately $11.6 million as of December 31, 2025 </em><br/><br/></li></ul> <p align="left">ROCKAWAY, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today provided select unaudited preliminary financial guidance for the full year and fourth quarter of 2025.</p> <p align="left"><strong>Financial Guidance</strong><br/>Preliminary unaudited financial guidance http://www.streetinsider.com/Press+Releases/electroCore+Provides+Preliminary+Full-Year+2025+Business+Update%3B+Expects+%7E26%25+Revenue+Growth+to+%7E%2431.8%E2%80%93%2432.0+Million/25864890.html Tue, 20 Jan 2026 08:00:00 -0400 A.15536158 ECOR O.07507914